Authors:
Norman, TR
Piccolo, J
Voudouris, N
Burrows, GD
Citation: Tr. Norman et al., The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers, PROG NEUR-P, 25(4), 2001, pp. 825-833
Citation: S. Dodd et al., Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography, J CHROMAT B, 748(2), 2000, pp. 439-443
Authors:
Tooley, GA
Armstrong, SM
Norman, TR
Sali, A
Citation: Ga. Tooley et al., Acute increases in night-time plasma melatonin levels following a period of meditation, BIOL PSYCH, 53(1), 2000, pp. 69-78
Authors:
Nathan, PJ
Wyndham, EL
Burrows, GD
Norman, TR
Citation: Pj. Nathan et al., The effect of gender on the melatonin suppression by light: a dose response relationship, J NEURAL TR, 107(3), 2000, pp. 271-279
Authors:
Dodd, S
Buist, A
Burrows, GD
Maguire, KP
Norman, TR
Citation: S. Dodd et al., Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography, J CHROMAT B, 730(2), 1999, pp. 249-255
Citation: Js. Olver et al., Discontinuation syndromes with selective serotonin reuptake inhibitors - Are there clinically relevant differences?, CNS DRUGS, 12(3), 1999, pp. 171-177
Citation: C. Mcgrath et Tr. Norman, (+)-S-20499 - a potential antidepressant? A behavioural and neurochemical investigation in the olfactory bulbectomised rat, EUR NEUROPS, 9(1-2), 1999, pp. 21-27
Citation: Pj. Nathan et al., Effect of the menstrual cycle stage on the melatonin suppression by dim white light, PSYCHONEURO, 24(2), 1999, pp. 193-200
Citation: Pj. Nathan et al., The effect of age and pre-light melatonin concentration on the melatonin sensitivity to dim light, INT CLIN PS, 14(3), 1999, pp. 189-192
Citation: C. Mcgrath et al., Treatment of anxiety during pregnancy - Effects of psychotropic drug treatment on the developing fetus, DRUG SAFETY, 20(2), 1999, pp. 171-186
Authors:
Cryan, JF
McGrath, C
Leonard, BE
Norman, TR
Citation: Jf. Cryan et al., Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat, PHARM BIO B, 63(2), 1999, pp. 333-338